Automated De Novo Drug Design: Are We Nearly There Yet?
Author:
Affiliation:
1. ETH ZurichDepartment of Chemistry and Applied Biosciences, RETHINK Vladimir-Prelog-Weg 4 8093 Zurich Switzerland
2. Charles River 6–9 Spire Green Centre Harlow Essex CM19 5TR UK
Funder
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Publisher
Wiley
Subject
General Chemistry,Catalysis
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/anie.201814681
Reference92 articles.
1. An analysis of the attrition of drug candidates from four major pharmaceutical companies
2. Is poor research the cause of the declining productivity of the pharmaceutical industry? An industry in need of a paradigm shift
3. Drug discovery in pharmaceutical industry: productivity challenges and trends
4. Editorial: A stronger role for science Nat. Rev. Drug Discovery2011 10 159.
5. How to improve R&D productivity: the pharmaceutical industry's grand challenge
Cited by 109 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. User-friendly and industry-integrated AI for medicinal chemists and pharmaceuticals;Artificial Intelligence Chemistry;2024-12
2. A Generative Evolutionary Many-Objective Framework: A Case Study in Antimicrobial Agent Design;Proceedings of the Genetic and Evolutionary Computation Conference Companion;2024-07-14
3. The Role of AI in Drug Discovery;ChemBioChem;2024-06-26
4. The use of artificial intelligence (AI) in pharmacology and the process of drug discovery;Medical Sciences Journal of Islamic Azad University;2024-06-01
5. Prospective de novo drug design with deep interactome learning;Nature Communications;2024-04-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3